#phase3

1 story

#biontech #european society for medical oncology #ibb #intismeran autogene #melanoma #merck #moderna #nasdaq:mrna #pembrolizumab #presidential symposium #spy

Moderna Jumps 9% After Melanoma Data Wins Prestigious Slot
Moderna stock surges 9% as Phase 3 melanoma trial data secures top presentation slot at major cancer conference
24/7 Wall St. · 1m